04.11.2010
- The U.S. Patent and Trademark's Board of Patent Appeals and Interferences has reconfirmed Hovione's patent claims to a method of making flumethasone and its 17-carboxyl androsten...
28.07.2010
- Hovione announced today that the consolidated sales for the fiscal year ended March 31 amounted to $144 million, representing an increase of 15% over the previous year. During 2009...
22.07.2010
- Hovione has announced the nomination of two of its scientists to the United States Pharmacopeia (USP), for the period 2010-2015. Jason Suggett, PhD has been named to the General...
